Cost-effectiveness of pelvic exenteration for locally advanced malignancy
CE Koh, T Badgery-Parker, G Salkeld, JM Young, AG Heriot, MJ Solomon
British Journal of Surgery | WILEY | Published : 2016
BACKGROUND: The rising cost of healthcare is well documented. The purpose of this study was to determine the cost-effectiveness of pelvic exenteration (PE). METHODS: Consecutive patients referred for consideration of PE between 2008 and 2011 were recruited into a prospective non-randomized study that compared quality of life (QoL) between patients who did or did not undergo PE. Information on QoL and cost (in Australian dollars, AUD) was collected at baseline, during admission and up to 24 months after discharge. QoL data were converted into a utility-based measure. Quality-adjusted life-years (QALYs) were calculated. Bottom-up costing was performed. The incremental cost-effectiveness ratio ..View full abstract
Awarded by Cancer Council Australia
This study was funded through the Priority-Driven Collaborative Cancer Research Scheme by Cancer Australia and the Cancer Council Australia (ID 570860). C.E.K. was also a recipient of the Foundation for Surgery Fellowship scholarship funded by the Royal Australasian College of Surgeons as well as the Notaras Fellowship.